-1.9 (-0.61%)
-3.3 (-1.05%) 3.32 pm | 08 May 2012 | Source: Reuters
Generic drugmaker Cipla is looking into cutting prices of more cancer drugs after it slashed the prices last week of three treatments by up to 75%, YK...
1.02 pm | 04 May 2012 | Source: Moneycontrol.com
Cipla's shocking 75% price cut of three cancer drugs on Thursday is unlikely to have a major impact on its earnings, analysts say....
5.00 pm | 03 May 2012 | Source: Reuters
Cipla has cut the price of the generic version of Bayer's renal cancer drug Nexavar by 75 percent and will sell it at 6,840 rupees for a monthly dose,...
4.26 pm | 25 Apr 2012 | Source: Reuters
Ranbaxy Laboratories, India's top drugmaker by sales, said it launched a new malaria treatment drug Synriam in the country and was working to introduc...
2.08 pm | 25 Apr 2012 | Source: CNBC-TV18
In an interview to CNBC-TV18, YK Hamied, chairman and managing director of Cipla says, the company is launching an anti-malarial drug in India. "Today...